STMicroelectronics, Nu Eyne Collaborate Over Eye Care Therapy Device

STMicroelectronics NV (NYSE:STM) and Korean medical device manufacturer Nu Eyne jointly announced a Nu Eyne wearable therapy device for eye care powered…

byAnusuya Lahiri

September 30, 2021

1 minute read

STMicroelectronics NV (NYSE:STM) and Korean medical device manufacturer Nu Eyne jointly announced a Nu Eyne wearable therapy device for eye care powered by an STM32WB55 dual-core Bluetooth LE (BLE) microcontroller (MCU).
Nu Eyne’s recently launched CELLENA wearable device uses electric current and light emitted to the eyes and associated nerves to relieve eye dryness and fatigue.
The CELLENA device relies on the dual-core architecture of the STM32WB55 MCU for wireless connectivity and real-time processing.
ST’s MCU also delivers multiple security mechanisms, including user data protection and encrypted firmware update over BLE with its embedded security features.
Price Action: STM shares traded higher by 0.81% at $43.69 in the premarket session on the last check Thursday.

Apple Supplier Foxconn Confirms Deal To Buy Lordstown Ohio Plant, Fisker PEAR Could Come Sooner

By Rachit Vats

October 1, 4:54 AM

Key Apple Inc (NASDAQ: AAPL) supplier Hon Hai Precision Industry Co., Ltd.

AAPL

Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday

By Lisa Levin

February 27, 11:21 AM

U.S. stocks traded higher, with the Dow Jones gaining more than 300 points on Monday. Here are some big stocks recording gains in today’s session.

AAMC

$100 Invested In Block 5 Years Ago Would Be Worth This Much

By Benzinga Insights

April 28, 2:11 PM

Block (NYSE:SQ) has outperformed the market over the past 5 years by 28.5% on an annualized basis producing an average annual return of 40.83%. Currently, Block has a market capitalization of $60.44 billion.

Gilead Reports Trodelvy Showed Clinical Benefit For Black Patients Consistent With Full Metastatic Triple-Negative Breast Cancer Population In ASCENT Study

By Benzinga Newsdesk

December 10, 9:00 AM

Disparities, Such as Access to Healthcare, Comorbidities and Differences in TNBC Disease Biology Typically Drive Worse Clinical Outcomes in Black Women – FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences,

GILD

STMicroelectronics, Nu Eyne Collaborate Over Eye Care Therapy Device

Related Posts

Apple Supplier Foxconn Confirms Deal To Buy Lordstown Ohio Plant, Fisker PEAR Could Come Sooner

Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday

$100 Invested In Block 5 Years Ago Would Be Worth This Much

Gilead Reports Trodelvy Showed Clinical Benefit For Black Patients Consistent With Full Metastatic Triple-Negative Breast Cancer Population In ASCENT Study